Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The E76K mutation in protein tyrosine phosphatase (PTP) SHP2 is a recurrent driver of developmental disorders and cancers, yet the mechanism by which this single-site substitution promotes persistent activation remains elusive. Here, we combine path-based conformational sampling, unbiased molecular dynamics (MD) simulations, Markov state models (MSMs), and neural relational inference (NRI) to elucidate how E76K reshapes the activation landscape and regulatory architecture of SHP2. Using a minimum-action trajectory derived from experimentally determined closed and open structures, we generated representative transition intermediates to guide the unbiased MD simulations. This strategy captured a thermodynamically relevant ensemble spanning the full activation process. MSMs analyses revealed that E76K flattens the energy landscape, stabilizes activation-prone conformations, and accelerates conformational transitions into catalytically competent states. NRI further uncovered a rewiring of allosteric communication networks, characterized by increased interdomain coupling and an elevated centrality of key relay residues. Shortest-path and temporal analyses revealed that the E76K-induced network remodeling precedes and facilitates domain opening, linking topological reorganization to structural activation. Together, our study provides a dynamic and mechanistic framework for understanding SHP2 activation by oncogenic mutation and illustrates the power of integrating ensemble modeling with interpretable network inference to dissect allosteric regulation.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acs.jcim.5c01201DOI Listing

Publication Analysis

Top Keywords

e76k mutation
8
shp2 activation
8
rewiring allosteric
8
conformational transitions
8
analyses revealed
8
activation
6
e76k
4
mutation promotes
4
shp2
4
promotes shp2
4

Similar Publications

The E76K mutation in protein tyrosine phosphatase (PTP) SHP2 is a recurrent driver of developmental disorders and cancers, yet the mechanism by which this single-site substitution promotes persistent activation remains elusive. Here, we combine path-based conformational sampling, unbiased molecular dynamics (MD) simulations, Markov state models (MSMs), and neural relational inference (NRI) to elucidate how E76K reshapes the activation landscape and regulatory architecture of SHP2. Using a minimum-action trajectory derived from experimentally determined closed and open structures, we generated representative transition intermediates to guide the unbiased MD simulations.

View Article and Find Full Text PDF

Juvenile myelomonocytic leukemia (JMML) is a rare pediatric malignancy without defined environmental triggers. We report two cases of JMML with identical somatic PTPN11 mutations in children exposed in utero to thiopurine-containing chemotherapy. One mother underwent antileukemic treatment including thioguanine during early pregnancy; the other received 6-mercaptopurine for Crohn's disease throughout gestation.

View Article and Find Full Text PDF

Innate immune mechanisms hijacked by leukemia-initiating stem cells for selective advantage and immune evasion in Ptpn11-associated JMML.

Cell Rep

August 2025

Department of Pediatrics, Aflac Cancer & Blood Disorders Center, Winship Cancer Institute, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, USA. Electronic address:

Juvenile myelomonocytic leukemia (JMML) originates from mutated hematopoietic stem cells. The mechanism by which mutant stem cells are sustained, leading to leukemia development, remains elusive. By comprehensively examining transcriptomic profiles, cell compositions, developmental trajectories, and cell-cell interactions across various stages of tumor cell development in a mouse model of Ptpn11 mutation-associated JMML, we find that Ptpn11 mutant stem cells exhibit de novo activation of the myeloid transcriptional program and markedly increased expression of innate immunity-associated antimicrobial peptides and pro-inflammatory proteins, particularly S100a9 and S100a8.

View Article and Find Full Text PDF

Allosteric inhibition rescues hydrocephalus caused by catalytically inactive Shp2.

bioRxiv

February 2025

Departments of Ophthalmology, Pathology and Cell Biology, Columbia University Irving Medical Center, Columbia University, New York, NY 10032, USA.

SHP2, a protein tyrosine phosphatase (PTP) crucial in Ras-MAPK signaling, is associated with various human congenital diseases and cancers. Here, we show that the catalytically inactive mutation results in communicating hydrocephalus, similar to the catalytically activating and mutants. Unlike previous mutants, however, mutation uniquely affects ciliary development rather than neurogenesis, leading to reduced cilia density and impaired ciliary motility.

View Article and Find Full Text PDF

Histiocytic sarcoma (HS) is a rare and highly aggressive cancer in humans and dogs. In dogs, it has a high prevalence in certain breeds, such as Bernese mountain dogs (BMDs) and flat-coated retrievers. Hemophagocytic histiocytic sarcoma (HHS) is a unique form of HS that presents with erythrophagocytosis.

View Article and Find Full Text PDF